Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD for Premenstrual Disorders (L4Her)
NCT07189299Not yet recruiting
- Start
- Oct 2025
- Primary completion
- Nov 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lysergide in premenstrual syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD) (3 arms). Primary endpoint: Change in premenstrual symptom burden. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Lysergide
03
Conditions
premenstrual syndrome (PMS)Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT07189299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189299.